OP OncoMed Pharmaceuticals Inc Stock: price and directors' dealings · United States · SEC (Form 4)Track the OncoMed Pharmaceuticals Inc share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was reported on 12 January 2016 (Levée d'options). Among the most active insiders: Dupont Jakob. All data is free.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 January 2016
All Executives22 Thresholds0 Prospectus0 Other0
Declarations 22 total
◇ SVP & Chief Medical Officer · Executives · 11 Jan 2016
2,500 shares Common Stock SEC:0001140361-16-047651:0
▼ SVP & Chief Medical Officer · Executives · 11 Jan 2016
2,500 shares Common Stock SEC:0001140361-16-047651:1
▼ SVP & Chief Medical Officer · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047340:0
▼ SVP & Chief Medical Officer · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047340:1
▼ SVP & Chief Medical Officer · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047340:2
▼ See Remarks · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047339:0
▼ See Remarks · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047339:1
▼ See Remarks · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047339:2
▼ Chairman & CEO · Executives · 6 Jan 2016
2,335 shares Common Stock SEC:0001140361-16-047336:0
▼ Chairman & CEO · Executives · 6 Jan 2016
77 shares Common Stock SEC:0001140361-16-047336:1
▼ VP & General Counsel · Executives · 6 Jan 2016
1,570 shares Common Stock SEC:0001140361-16-047335:0
▼ VP & General Counsel · Executives · 6 Jan 2016
52 shares Common Stock SEC:0001140361-16-047335:1
▼ VP & General Counsel · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047335:2
▼ SVP, Cancer Biology · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047337:0
▼ SVP, Cancer Biology · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047337:1
▼ SVP, Cancer Biology · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047337:2
▼ EVP & Chief Scientific Officer · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047333:0
▼ EVP & Chief Scientific Officer · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047333:1
▼ EVP & Chief Scientific Officer · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047333:2
▼ See Remarks · Executives · 6 Jan 2016
2,092 shares Common Stock SEC:0001140361-16-047334:0
▼ See Remarks · Executives · 6 Jan 2016
69 shares Common Stock SEC:0001140361-16-047334:1
▼ See Remarks · Executives · 7 Jan 2016
1 shares Common Stock SEC:0001140361-16-047334:2
关于 OncoMed Pharmaceuticals Inc OncoMed Pharmaceuticals Inc 是一家生物制药公司，专注于开发创新的癌症治疗方法。该公司专门从事靶向肿瘤干细胞药物的发现和开发。